Denali Therapeutics Inc. (DNLI) Ownership

$18.72

south_east
-$0.87 (-4.44%)
Day's range
$18.52
Day's range
$19.9

Denali Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 11/13/2024 13.79 M $401.66 M   100.00% 8.14%
BAILLIE GIFFORD & CO 11/05/2024 13.35 M $388.77 M   -3.03% 7.88%
VANGUARD GROUP INC 11/13/2024 11.18 M $325.59 M   -1.20% 6.60%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2024 10.73 M $312.49 M   9.20% 6.33%
CAPITAL RESEARCH GLOBAL INVESTORS 11/13/2024 7.91 M $230.39 M   10.98% 4.67%
FMR LLC 11/13/2024 7.83 M $228.13 M   3,234.35% 4.62%
TEMASEK HOLDINGS (PRIVATE) LTD 11/14/2024 5.36 M $156.02 M   -6.14% 3.16%
CRESTLINE MANAGEMENT, LP 11/13/2024 4.46 M $129.94 M   -6.30% 2.63%
STATE STREET CORP 11/14/2024 4.25 M $123.86 M   -4.12% 2.51%
BAKER BROS. ADVISORS LP 11/14/2024 3.73 M $108.70 M   0.00% 2.20%
ALLIANCEBERNSTEIN L.P. 11/14/2024 3.05 M $88.77 M   50.96% 1.80%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 2.96 M $86.11 M   -0.91% 1.74%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 2.87 M $83.60 M   27.24% 1.69%
CAMBER CAPITAL MANAGEMENT LP 11/14/2024 2.00 M $58.26 M   0.00% 1.18%
MARSHALL WACE, LLP 11/14/2024 1.97 M $57.30 M   -18.67% 1.16%
MORGAN STANLEY 11/14/2024 1.74 M $50.82 M   42.56% 1.03%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 1.56 M $45.43 M   10.02% 0.92%
GOLDMAN SACHS GROUP INC 11/14/2024 1.37 M $39.84 M   12.22% 0.81%
BANK OF NEW YORK MELLON CORP 11/12/2024 1.33 M $38.75 M   -13.63% 0.79%
PRINCIPAL FINANCIAL GROUP INC 10/31/2024 1.24 M $36.08 M   13.77% 0.73%
ARTISAN PARTNERS LIMITED PARTNERSHIP 11/12/2024 1.09 M $31.78 M   -4.42% 0.64%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 1.02 M $29.59 M   -4.11% 0.60%
CASDIN CAPITAL, LLC 11/14/2024 990,000 $28.84 M   -23.85% 0.58%
CANDRIAM S.C.A. 11/13/2024 942,158 $27.44 M   29.68% 0.56%
SIREN, L.L.C. 11/13/2024 834,028 $24.30 B   100.00% 0.49%
CITADEL ADVISORS LLC 11/14/2024 777,280 $22.64 M   -36.22% 0.46%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 715,300 $20.84 M   -33.39% 0.42%
CERCANO MANAGEMENT LLC 11/14/2024 625,000 $18.21 M   0.00% 0.37%
YIHENG CAPITAL MANAGEMENT, L.P. 11/12/2024 600,098 $17.48 M   -47.85% 0.35%
FISHER ASSET MANAGEMENT, LLC 11/12/2024 547,331 $15.94 M   14.48% 0.32%
AMERICAN CENTURY COMPANIES INC 11/12/2024 451,374 $13.15 M   -13.63% 0.27%
CLARIUS GROUP, LLC 10/09/2024 409,995 $11.94 M   0.00% 0.24%
JANE STREET GROUP, LLC 11/15/2024 369,671 $10.77 M   59.78% 0.22%
ABRDN PLC 10/25/2024 363,679 $10.59 M   -36.53% 0.21%
BANK OF AMERICA CORP /DE/ 11/14/2024 348,164 $10.14 M   -53.08% 0.21%
ENSIGN PEAK ADVISORS, INC 11/14/2024 346,304 $10.09 M   0.00% 0.20%
AXA S.A. 11/14/2024 344,883 $10.05 M   0.03% 0.20%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2024 333,530 $9.72 M   -68.33% 0.20%
STEMPOINT CAPITAL LP 11/13/2024 282,050 $8.22 M   12.37% 0.17%
BARCLAYS PLC 11/19/2024 255,883 $7.45 M   101.39% 0.15%
SWISS NATIONAL BANK 11/07/2024 250,700 $7.30 M   7.69% 0.15%
TD ASSET MANAGEMENT INC 11/01/2024 244,552 $7.20 M   36.51% 0.14%
WASATCH ADVISORS LP 11/14/2024 238,881 $6.96 M   -40.64% 0.14%
JPMORGAN CHASE & CO 12/26/2024 235,386 $6.86 M   6.48% 0.14%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 11/18/2024 207,124 $6.03 M   0.00% 0.12%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/13/2024 206,819 $6.02 M   20.05% 0.12%
INVESCO LTD. 11/12/2024 206,363 $6.01 M   77.54% 0.12%
EDMOND DE ROTHSCHILD HOLDING S.A. 11/14/2024 205,680 $5.99 M   0.00% 0.12%
RHUMBLINE ADVISERS 11/12/2024 189,893 $5.53 M   -2.55% 0.11%
PIER CAPITAL, LLC 11/15/2024 168,082 $4.90 M   1.57% 0.10%

Denali Therapeutics Inc.institutional Ownership - FAQ's

Who are the largest shareholders of DNLI shares?

During the previous two years, 261 institutional investors and hedge funds held shares of Denali Therapeutics Inc.. The most heavily invested institutionals were:

AdvisorNet Financial, Inc: 0

BlackRock Funding, Inc. /DE: 13.79 M

BAILLIE GIFFORD & CO: 13.35 M

VANGUARD GROUP INC: 11.18 M

WELLINGTON MANAGEMENT GROUP LLP: 10.73 M

Capital Research Global Investors: 7.91 M

What percentage of Denali Therapeutics Inc. stock is owned by institutional investors?

74.56% of Denali Therapeutics Inc. stock is owned by institutional investors.

How much institutional buying is happening at DNLI ?

Institutional investors have bought a total of 139.84 M shares in the last 24 months. This purchase volume represents approximately $2.62 B in transactions.